Pre-Gestational Diabetes and Pregnancy Outcomes
- PMID: 33010001
- PMCID: PMC7644712
- DOI: 10.1007/s13300-020-00932-9
Pre-Gestational Diabetes and Pregnancy Outcomes
Abstract
Introduction: Pre-gestational, type 1 and type 2 diabetes are associated with adverse neonatal outcomes and increased rates of emergency caesarean sections.
Methods: We studied pregnancy outcomes associated with pre-gestational diabetes in 174 women who attended the National Maternity Hospital in Dublin, Ireland, between 2015 and 2017.
Results: Fifty women (28.6%) had type 2 diabetes mellitus, and 124 women (71.4%) had type 1 diabetes mellitus. Women with type 2 diabetes mellitus were older (36 vs. 34 years, p 0.02) and had a higher BMI (32.6 vs. 26.2 kg/m2, p 0.00). Duration of diabetes mellitus in type 1 and type 2 was 15.7 and 5.7 years, respectively, and mean HbA1c in type 2 diabetes mellitus at booking was 44.5 mmol/mol (6.2%) and in type 1 diabetes mellitus was 56.3 mmol/mol (7.3%). Forty women (32%) with type 1 diabetes mellitus used continuous subcutaneous insulin infusion. In our cohort, 45.4% had a caesarean delivery. Offspring of patients with multiple dose injections were lighter (3.58 kg) than infants of continuous subcutaneous insulin infusion-treated patients (3.75 kg). More emergency caesarean sections were observed in the continuous subcutaneous insulin infusion group than in the group treated with multiple dose injections (37.5% vs. 28.5%), while the elective caesarean section rate was higher in the multiple dose injection group (17.8% vs. 12.5%). Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage (25% vs. 19%) with more congenital malformations (10% vs. 2.3%).
Conclusions: Women in our study with pre-gestational diabetes were overweight, were older and had long-standing diabetes mellitus. Our patients with type 2 diabetes had a higher BMI, were older, had a shorter duration of diabetes mellitus and had better diabetes control compared to women with type 1 diabetes. Women treated with continuous subcutaneous insulin infusion had a higher rate of miscarriage with more congenital malformations. The initial inadequate diabetes control was significantly improved during pregnancy.
Keywords: Diabetes; Diabetes in pregnancy; Pre-gestational pregnancy and diabetes outcomes; Type 1 diabetes; Type 2 diabetes.
Similar articles
-
Pregnancy outcomes among women with type 1 diabetes mellitus using continuous subcutaneous insulin infusion versus multiple daily injections: A retrospective cohort study.Obstet Med. 2019 Sep;12(3):136-142. doi: 10.1177/1753495X18797769. Epub 2018 Nov 7. Obstet Med. 2019. PMID: 31523270 Free PMC article.
-
Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.Am J Obstet Gynecol. 2018 Aug;219(2):191.e1-191.e6. doi: 10.1016/j.ajog.2018.05.003. Epub 2018 May 8. Am J Obstet Gynecol. 2018. PMID: 29750952
-
Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance.Diabetologia. 2019 Nov;62(11):2118-2128. doi: 10.1007/s00125-019-4961-7. Epub 2019 Jul 23. Diabetologia. 2019. PMID: 31338546
-
Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.Eur J Endocrinol. 2018 May;178(5):545-563. doi: 10.1530/EJE-17-0804. Epub 2018 Mar 15. Eur J Endocrinol. 2018. PMID: 29545258 Review.
-
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005542. doi: 10.1002/14651858.CD005542.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2016 Jun 07;(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. PMID: 17636806 Updated. Review.
Cited by
-
Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study.Med Sci (Basel). 2024 Apr 15;12(2):21. doi: 10.3390/medsci12020021. Med Sci (Basel). 2024. PMID: 38651415 Free PMC article.
-
Gestational diabetes in mice induces hematopoietic memory that affects the long-term health of the offspring.J Clin Invest. 2024 Jan 16;134(2):e169730. doi: 10.1172/JCI169730. J Clin Invest. 2024. PMID: 37988162 Free PMC article.
-
Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.J Diabetes Sci Technol. 2023 Sep;17(5):1337-1363. doi: 10.1177/19322968231186626. Epub 2023 Aug 4. J Diabetes Sci Technol. 2023. PMID: 37542367 Review.
-
The association between maternal diabetes and neonatal seizures: a nested case-Control study.Front Pediatr. 2023 Jul 13;11:1145443. doi: 10.3389/fped.2023.1145443. eCollection 2023. Front Pediatr. 2023. PMID: 37520060 Free PMC article.
-
Analysis of Maternal and Neonatal Complications in a Group of Patients with Gestational Diabetes Mellitus.Medicina (Kaunas). 2021 Oct 28;57(11):1170. doi: 10.3390/medicina57111170. Medicina (Kaunas). 2021. PMID: 34833388 Free PMC article.
References
-
- Murphy HR, Bell R, Cartwright C, Curnow P, Maresh M, Morgan M, Lewis-Barned N. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia. 2017;60(9):1668–1677. doi: 10.1007/s00125-017-4314-3. - DOI - PMC - PubMed
-
- Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golighty S, Miller A. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetesin England, Wales, and Northern Ireland: population based study. BMJ. 2006;333(7560):177–183. doi: 10.1136/bmj.38856.692986.AE. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources